Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0282348 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Angel Carvajal-Oliveros und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Méxi…. Hauptthemen laut MEDLINE: Nicotine, Parkinsonian Disorders, Nerve Tissue Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, CONACYT.
Abstract (Originalsprache)
Synphilin-1 is a protein encoded by the human SNCAIP gene whose function has yet to be fully understood. However, it has been linked to familial Parkinson’s disease (PD). Synphilin-1 is a major component of the Lewy bodies found in neurons in the substantia nigra pars compacta of PD patients. Synphilin-1 expression in serotonergic and/or dopaminergic neurons of Drosophila melanogaster induces neurodegeneration, as well as motor and non-motor PD like symptoms. In this work, we examined the contribution of the serotonergic and dopaminergic circuits in the development of PD-like phenotypes. We found that olfactory and visual symptoms are majorly contributed by the serotonergic system, and that motor symptoms and reduction in survival are mainly contributed by the dopaminergic system. Chronic nicotine treatment was able to suppress several of these symptoms. These results indicate that both the serotonergic and dopaminergic systems contribute to different aspects of PD symptomatology and that nicotine has beneficial effects on specific symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, México.
- Facultad de Ciencias Biológicas, Departamento de Biología Celular y Molecular, Laboratorio Neurogenética de la Conducta, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México.
ORCID-Profile: Jorge M Campusano, Enrique Reynaud
Förderung
- Consejo Nacional de Ciencia y Tecnología
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
- CONACYT
- PAEP-UNAM
- Alianza del Pacífico- AGCID
Zitieren
APA
Carvajal-Oliveros, A., Dominguez-Baleón, C., Sánchez-Díaz, I., Zambrano-Tipan, D., Hernández-Vargas, R., Campusano, J. M., Narváez-Padilla, V., & Reynaud, E. (2023). Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment. PLOS ONE. https://doi.org/10.1371/journal.pone.0282348
Vancouver
Carvajal-Oliveros A, Dominguez-Baleón C, Sánchez-Díaz I, Zambrano-Tipan D, Hernández-Vargas R, Campusano JM, et al. Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment. PLOS ONE. 2023. doi:10.1371/journal.pone.0282348
BibTeX
@article{CarvajalOliveros2023,
author = {Carvajal-Oliveros, Angel and Dominguez-Baleón, Carmen and Sánchez-Díaz, Iván and Zambrano-Tipan, Diego and Hernández-Vargas, René and Campusano, Jorge M and Narváez-Padilla, Verónica and Reynaud, Enrique},
title = {Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0282348}
}
EUVIMED